Brief: Clearmind Medicine Announces Submission Of US Patent Application For Treating Metabolic Syndrome And Weight-Loss
16/07/2024 11:34
July 16 (Reuters) - Clearmind Medicine Inc CMND.O :
* CLEARMIND MEDICINE ANNOUNCES SUBMISSION OF US PATENT
APPLICATION
FOR TREATING METABOLIC SYNDROME AND WEIGHT-LOSS
Source text for Eikon: ID:nGNX8qN7nC
Further company coverage: CMND.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM